RxDoctor Payments Data

Benjamin Gocial

Reproductive Endocrinology · Philadelphia, PANPI 1104983766

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (43.5%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. Olympus America Inc. accounts for 77.4% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $14,752 and has fallen 97.2% since, to $408 in 2025.

$16,285in general payments, 2019–2025

Across 109 payments — averaging $149.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus America Inc.$13K
  • Olympus Corporation Of The Americas$1K
  • Ferring Pharmaceuticals Inc.$524
  • Olympus Corporation$300
  • Organon$264
  • Caldera Medical, Inc$259
  • plus $924 from 11 others
$148,305in research payments, 2019–2025

Across 15 payments — averaging $9887.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • IBSA Institut Biochimique SA$148K

What the payments were for

  • Consulting fees$7,08844%
  • Speaking & faculty fees$3,30020%
  • Travel & lodging$3,70823%
  • Food & beverage$2,17713%
  • Education$120%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,285 in reported general payments places this provider in the 85th percentile of 71 reproductive endocrinology providers in Pennsylvania.

See all reproductive endocrinology providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated12$7,254

Paid to pharmacies, not to this prescriber.

Other reproductive endocrinology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →